Works by Chanan‐Khan, Asher

Results: 120
    1

    Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities.

    Published in:
    2018
    By:
    • Ailawadhi, Sikander;
    • Frank, Ryan D.;
    • Sharma, Mayank;
    • Menghani, Richa;
    • Temkit, M'hamed;
    • Paulus, Shumail;
    • Khera, Nandita;
    • Hashmi, Shahrukh;
    • Advani, Pooja;
    • Swaika, Abhisek;
    • Paulus, Aneel;
    • Aslam, Nabeel;
    • Sher, Taimur;
    • Roy, Vivek;
    • Colon‐Otero, Gerardo;
    • Chanan‐Khan, Asher;
    • Temkit, M'hamed;
    • Colon-Otero, Gerardo;
    • Chanan-Khan, Asher
    Publication type:
    journal article
    2

    AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma.

    Published in:
    Cancers, 2023, v. 15, n. 2, p. 477, doi. 10.3390/cancers15020477
    By:
    • Ailawadhi, Sikander;
    • Parrondo, Ricardo D.;
    • Dutta, Navnita;
    • Han, Bing;
    • Ciccio, Gina;
    • Cherukuri, Yesesri;
    • Alegria, Victoria R.;
    • LaPlant, Betsy R.;
    • Roy, Vivek;
    • Sher, Taimur;
    • Edwards, Brett;
    • Lanier, Stephanie;
    • Manna, Alak;
    • Heslop, Keisha;
    • Caulfield, Thomas;
    • Maldosevic, Emir;
    • Storz, Peter;
    • Manochakian, Rami;
    • Asmann, Yan;
    • Chanan-Khan, Asher A.
    Publication type:
    Article
    3
    4
    5

    Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00752-z
    By:
    • Zanwar, Saurabh;
    • Ho, Matthew;
    • Buadi, Francis K.;
    • Ailawadhi, Sikander;
    • Larsen, Jeremy;
    • Bergsagel, Leif;
    • Binder, Moritz;
    • Chanan-Khan, Asher;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Fonseca, Rafael;
    • Gertz, Morie A.;
    • Gonsalves, Wilson;
    • Go, Ronald S.;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Lacy, Martha Q.;
    • Leung, Nelson;
    • Lin, Yi
    Publication type:
    Article
    6
    7

    Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00721-6
    By:
    • Hampel, Paul J.;
    • Rabe, Kari G.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Leis, Jose F.;
    • Chanan-Khan, Asher A.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Wang, Yucai;
    • Ailawadhi, Sikander;
    • Koehler, Amber B.;
    • Parrondo, Ricardo;
    • Schwager, Susan M.;
    • Sher, Taimur;
    • Hanson, Curtis A.;
    • Shi, Min;
    • Van Dyke, Daniel L.;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.
    Publication type:
    Article
    8
    9
    10

    Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia.

    Published in:
    Blood Cancer Journal, 2019, v. 9, n. 10, p. N.PAG, doi. 10.1038/s41408-019-0237-1
    By:
    • Kumar, Vivek;
    • Ailawadhi, Sikander;
    • Bojanini, Leyla;
    • Mehta, Aditya;
    • Biswas, Suman;
    • Sher, Taimur;
    • Roy, Vivek;
    • Vishnu, Prakash;
    • Marin-Acevedo, Julian;
    • Alegria, Victoria R.;
    • Paulus, Aneel;
    • Aulakh, Sonikpreet;
    • Iqbal, Madiha;
    • Manochakian, Rami;
    • Tan, Winston;
    • Chanan-Khan, Asher;
    • Ailawadhi, Meghna
    Publication type:
    Article
    11
    12
    13

    Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 13, p. 3188, doi. 10.1080/10428194.2020.1795159
    By:
    • Fraser, Graeme A.M.;
    • Chanan-Khan, Asher;
    • Demirkan, Fatih;
    • Santucci Silva, Rodrigo;
    • Grosicki, Sebastian;
    • Janssens, Ann;
    • Mayer, Jiri;
    • Bartlett, Nancy L.;
    • Dilhuydy, Marie-Sarah;
    • Loscertales, Javier;
    • Avigdor, Abraham;
    • Rule, Simon;
    • Samoilova, Olga;
    • Pavlovsky, Miguel A.;
    • Goy, Andre;
    • Mato, Anthony;
    • Hallek, Michael;
    • Salman, Mariya;
    • Tamegnon, Monelle;
    • Sun, Steven
    Publication type:
    Article
    14
    15

    Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 11, p. 2712, doi. 10.1080/10428194.2019.1602268
    By:
    • Hampel, Paul J.;
    • Ding, Wei;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Kenderian, Saad S.;
    • Witzig, Thomas E.;
    • Muchtar, Eli;
    • Leis, Jose F.;
    • Chanan-Khan, Asher A.;
    • Koehler, Amber B.;
    • Fonder, Amie L.;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Shanafelt, Tait D.;
    • Kay, Neil E.;
    • Parikh, Sameer A.
    Publication type:
    Article
    16

    Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS study

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 9, p. 2075, doi. 10.1080/10428194.2017.1416364
    By:
    • Cramer, Paula;
    • Traina, Shana;
    • Chan, Eric K. H.;
    • Mahler, Michelle;
    • Salman, Mariya;
    • Diels, Joris;
    • Sengupta, Nishan;
    • Howes, Angela;
    • Chanan-Khan, Asher;
    • Fraser, Graeme;
    • Santucci-Silva, Rodrigo;
    • Grosicki, Sebastian;
    • Dilhuydy, Marie-Sarah;
    • Janssens, Ann;
    • Loscertales, Javier;
    • Rule, Simon;
    • Goy, Andre
    Publication type:
    Article
    17

    Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL).

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 7, p. 1630, doi. 10.1080/10428194.2016.1257795
    By:
    • Shanafelt, Tait D.;
    • Parikh, Sameer A.;
    • Noseworthy, Peter A.;
    • Goede, Valentin;
    • Chaffee, Kari G.;
    • Bahlo, Jasmin;
    • Call, Timothy G.;
    • Schwager, Susan M.;
    • Ding, Wei;
    • Eichhorst, Barbara;
    • Fischer, Kirsten;
    • Leis, Jose F.;
    • Chanan-Khan, Asher Alban;
    • Hallek, Michael;
    • Slager, Susan L.;
    • Kay, Neil E.
    Publication type:
    Article
    18

    Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practice.

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 6, p. 1376, doi. 10.1080/10428194.2016.1251592
    By:
    • Finnes, Heidi D.;
    • Chaffee, Kari G.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Kenderian, Saad S.;
    • Bowen, Deborah A.;
    • Conte, Michael;
    • McCullough, Kristen B.;
    • Merten, Julianna A.;
    • Bartoo, Gabriel T.;
    • Smith, Matthew D.;
    • Leis, Jose;
    • Chanan-Khan, Asher;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Shanafelt, Tait D.;
    • Parikh, Sameer A.
    Publication type:
    Article
    19

    Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial*.

    Published in:
    Leukemia & Lymphoma, 2016, v. 57, n. 6, p. 1291, doi. 10.3109/10428194.2015.1128540
    By:
    • Wendtner, Clemens M.;
    • Hallek, Michael;
    • Fraser, Graeme A. M.;
    • Michallet, Anne-Sophie;
    • Hillmen, Peter;
    • Dürig, Jan;
    • Kalaycio, Matt;
    • Gribben, John G.;
    • Stilgenbauer, Stephan;
    • Buhler, Andreas;
    • Kipps, Thomas J.;
    • Purse, Brendan;
    • Zhang, Jennie;
    • De Bedout, Sabine;
    • Mei, Jay;
    • Chanan-Khan, Asher
    Publication type:
    Article
    20

    Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib (PD-0332991) with bortezomib and dexamethasone in relapsed/refractory multiple myeloma.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 12, p. 3320, doi. 10.3109/10428194.2015.1030641
    By:
    • Niesvizky, Ruben;
    • Badros, Ashraf Z.;
    • Costa, Luciano J.;
    • Ely, Scott A.;
    • Singhal, Seema B.;
    • Stadtmauer, Edward A.;
    • Haideri, Nisreen A.;
    • Yacoub, Abdulraheem;
    • Hess, Georg;
    • Lentzsch, Suzanne;
    • Spicka, Ivan;
    • Chanan-Khan, Asher A.;
    • Raab, Marc S.;
    • Tarantolo, Stefano;
    • Vij, Ravi;
    • Zonder, Jeffrey A.;
    • Huang, Xiangao;
    • Jayabalan, David;
    • Di Liberto, Maurizio;
    • Huang, Xin
    Publication type:
    Article
    21
    22
    23
    24
    25

    Risk factors for severe infection and mortality In patients with COVID‐19 in patients with multiple myeloma and AL amyloidosis.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 1, p. 49, doi. 10.1002/ajh.26762
    By:
    • Ho, Matthew;
    • Zanwar, Saurabh;
    • Buadi, Francis K.;
    • Ailawadhi, Sikander;
    • Larsen, Jeremy;
    • Bergsagel, Leif;
    • Binder, Moritz;
    • Chanan‐Khan, Asher;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Fonseca, Rafael;
    • Gertz, Morie A.;
    • Gonsalves, Wilson;
    • Go, Ronald S.;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Lacy, Martha Q.;
    • Leung, Nelson;
    • Lin, Yi
    Publication type:
    Article
    26

    IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 3, p. 338, doi. 10.1002/ajh.25385
    By:
    • Fang, Hong;
    • Reichard, Kaaren K.;
    • Rabe, Kari G.;
    • Hanson, Curtis A.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Schwager, Susan M.;
    • Leis, Jose F.;
    • Chanan‐Khan, Asher A.;
    • Slager, Susan L.;
    • Braggio, Esteban;
    • Smoley, Stephanie A.;
    • Kay, Neil E.;
    • Shanafelt, Tait D.;
    • Van Dyke, Daniel L.;
    • Parikh, Sameer A.
    Publication type:
    Article
    27

    Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 12, p. 1362, doi. 10.1002/ajh.24915
    By:
    • Hampel, Paul J.;
    • Chaffee, Kari G.;
    • King, Rebecca L.;
    • Simonetto, Douglas;
    • Larson, Melissa C.;
    • Achenbach, Sara;
    • Call, Timothy G.;
    • Ding, Wei;
    • Kenderian, Saad S.;
    • Leis, Jose F.;
    • Chanan-Khan, Asher A.;
    • Bowen, Deborah A.;
    • Conte, Michael J.;
    • Schwager, Susan M.;
    • Hanson, Curtis A.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Shanafelt, Tait D.;
    • Parikh, Sameer A.
    Publication type:
    Article
    28
    29
    30

    CLL-115: First Results of a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S318, doi. 10.1016/S2152-2650(21)01750-X
    By:
    • Byrd, John C.;
    • Hillmen, Peter;
    • Ghia, Paolo;
    • Kater, Arnon P.;
    • Chanan-Khan, Asher;
    • Furman, Richard R.;
    • O'Brien, Susan;
    • Yenerel, Mustafa Nuri;
    • Illes, Arpad;
    • Kay, Neil;
    • Garcia-Marco, Jose A.;
    • Mato, Anthony;
    • Pinilla-Ibarz, Javier;
    • Seymour, John F.;
    • Lepretre, Stephane;
    • Stilgenbauer, Stephan;
    • Robak, Tadeusz;
    • Patel, Priti;
    • Higgins, Kara;
    • Sohoni, Sophia
    Publication type:
    Article
    31

    Poster: CLL-115: First Results of a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S220, doi. 10.1016/S2152-2650(21)01389-6
    By:
    • Byrd, John C.;
    • Hillmen, Peter;
    • Ghia, Paolo;
    • Kater, Arnon P.;
    • Chanan-Khan, Asher;
    • Furman, Richard R.;
    • O'Brien, Susan;
    • Yenerel, Mustafa Nuri;
    • Illes, Arpad;
    • Kay, Neil;
    • Garcia-Marco, Jose A.;
    • Mato, Anthony;
    • Pinilla-Ibarz, Javier;
    • Seymour, John F.;
    • Lepretre, Stephane;
    • Stilgenbauer, Stephan;
    • Robak, Tadeusz;
    • Patel, Priti;
    • Higgins, Kara;
    • Sohoni, Sophia
    Publication type:
    Article
    32

    Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell Leukemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. 355, doi. 10.1016/j.clml.2021.01.002
    By:
    • Parrondo, Ricardo D.;
    • Moustafa, Muhamad Alhaj;
    • Reeder, Craig;
    • Sher, Taimur;
    • Roy, Vivek;
    • Muchtar, Eli;
    • Warsame, Rahma;
    • Alegria, Victoria;
    • Gonsalves, Wilson;
    • Dingli, David;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Chanan-Khan, Asher A.;
    • Ailawadhi, Sikander
    Publication type:
    Article
    33

    Trends in Early Mortality From Multiple Myeloma: A Population-Based Analysis.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. e449, doi. 10.1016/j.clml.2020.12.023
    By:
    • Kumar, Vivek;
    • Ailawadhi, Meghna;
    • Dutta, Navnita;
    • Abdulazeez, Mays;
    • Aggarwal, Chander Shekher;
    • Quintero, Gerson;
    • Baksh, Mizba;
    • Roy, Vivek;
    • Taimur Sher;
    • Alegria, Victoria;
    • Paulus, Aneel;
    • Chanan-Khan, Asher;
    • Ailawadhi, Sikander
    Publication type:
    Article
    34

    Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia.

    Published in:
    2019
    By:
    • Kipps, Thomas J.;
    • Fraser, Graeme;
    • Coutre, Steven E.;
    • Brown, Jennifer R.;
    • Barrientos, Jacqueline C.;
    • Barr, Paul M.;
    • Byrd, John C.;
    • O'Brien, Susan M.;
    • Dilhuydy, Marie-Sarah;
    • Hillmen, Peter;
    • Jaeger, Ulrich;
    • Moreno, Carol;
    • Cramer, Paula;
    • Stilgenbauer, Stephan;
    • Chanan-Khan, Asher A.;
    • Mahler, Michelle;
    • Salman, Mariya;
    • Eckert, Karl;
    • Solman, Isabelle G.;
    • Balasubramanian, Sriram
    Publication type:
    journal article
    35
    36
    37
    38

    A Phase 1b Study of Venetoclax Combined with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e16, doi. 10.1016/j.clml.2017.03.027
    By:
    • Moreau, Philippe;
    • Chanan-Khan, Asher;
    • Roberts, Andrew W.;
    • Agarwal, Amit B.;
    • Facon, Thierry;
    • Kumar, Shaji;
    • Touzeau, Cyrille;
    • Cordero, Jaclyn;
    • Ross, Jeremy;
    • Munasinghe, Wijith;
    • Jia, Jia;
    • Salem, Ahmed H.;
    • Leverson, Joel;
    • Maciag, Paulo;
    • Verdugo, Maria;
    • Harrison, Simon J.
    Publication type:
    Article
    39
    40

    Daratumumab, Bortezomib and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in RRMM Based on Prior Lines and Treatment Exposure: CASTOR.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e133, doi. 10.1016/j.clml.2017.03.240
    By:
    • Lentzsch, Suzanne;
    • Nooka, Ajay;
    • Quach, Hang;
    • Lee, Cindy;
    • Barreto, Wolney;
    • Corradini, Paolo;
    • Min, Chang Ki;
    • Scott, Emma;
    • Chanan-Khan, Asher;
    • Horvath, Noemi;
    • Capra, Marcelo;
    • Beksac, Meral;
    • Ovilla, Roberto;
    • Jo, Jae-Cheol;
    • Shin, Ho-Jin;
    • Soong, David;
    • Casneuf, Tineke;
    • Chiu, Christopher;
    • Qin, Xiang;
    • Amin, Himal
    Publication type:
    Article
    41
    42

    Front Cover: Synthesis, Computational Docking Study, and Biological Evaluation of a Library of Heterocyclic Curcuminoids with Remarkable Antitumor Activity (ChemMedChem 18/2018).

    Published in:
    ChemMedChem, 2018, v. 13, n. 18, p. 1853, doi. 10.1002/cmdc.201800584
    By:
    • Laali, Kenneth K.;
    • Greves, William J.;
    • Zwarycz, Angela T.;
    • Correa Smits, Sebastian J.;
    • Troendle, Frederick J.;
    • Borosky, Gabriela L.;
    • Akhtar, Sharoon;
    • Manna, Alak;
    • Paulus, Aneel;
    • Chanan‐Khan, Asher;
    • Nukaya, Manabu;
    • Kennedy, Gregory D.
    Publication type:
    Article
    43
    44
    45
    46

    Utilization of radiation therapy in multiple myeloma: trends and changes in practice.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 3, p. 735, doi. 10.1007/s00277-020-04371-1
    By:
    • Ailawadhi, Sikander;
    • Frank, Ryan;
    • Ailawadhi, Meghna;
    • Kanji, Zahara;
    • Jani, Prachi;
    • Fiala, Mark;
    • Abdulazeez, Mays;
    • Ahmed, Salman;
    • Aggarwal, Chander Shekher;
    • Aulakh, Sonikpreet;
    • Hodge, David;
    • Roy, Vivek;
    • Alegria, Victoria R.;
    • Paulus, Aneel;
    • Chanan-Khan, Asher;
    • Sher, Taimur
    Publication type:
    Article
    47
    48

    Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 1, p. 143, doi. 10.1007/s00277-020-04094-3
    By:
    • Archibald, William J.;
    • Rabe, Kari G.;
    • Kabat, Brian F.;
    • Herrmann, Joerg;
    • Ding, Wei;
    • Kay, Neil E.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Leis, Jose F.;
    • Wang, Yucai;
    • Chanan-Khan, Asher A.;
    • Schwager, Susan M.;
    • Koehler, Amber B.;
    • Fonder, Amie L.;
    • Slager, Susan L.;
    • Shanafelt, Tait D.;
    • Call, Timothy G.;
    • Parikh, Sameer A.
    Publication type:
    Article
    49
    50